Devices › Device types
FDA product code NDN · class 2 · Orthopedic
Cement, bone, vertebroplasty: medical device reports filed with FDA
4,843 reports carry this product code, 2004–2026; 11 brands with a page.
- 4,843
- reports with this product code
- 0% of all MAUDE reports
- 615
- reports, 12 months to August 2026
- 603 in the 12 months before
- 74.9%
- classified as malfunction
- 62.3% across all reports
- 1.9%
- classified as death, as reported
- 0.9% across all reports
Product code NDN is FDA's classification for "Cement, bone, vertebroplasty" (orthopedic panel), a class 2 device. 4,843 medical device reports carry this product code, 0% of the MAUDE database, from February 2004 to August 2026.
615 reports arrived in the 12 months to August 2026, close to the 603 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (74.9%), injury (22.4%) and death (1.9%). 11 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Kyphx Hv-R Bone Cement | 913 | 7 | 3.4% | 65.3% |
| Vertecem V+ Cement Kit | 693 | 98 | 0.1% | 91.7% |
| KYPHON HV-R Bone Cement | 314 | 110 | 0.3% | 91.1% |
| Confidence Kit No Needles | 175 | 8 | 5.1% | 92% |
| Confidence Spinal Cmt Sys 11c | 170 | 14 | 1.8% | 85.9% |
| KYPHON Xpede Bone Cement | 168 | 38 | 3% | 84.5% |
| Synflate Balloon/Medium- Sterile | 164 | 66 | 0% | 99.4% |
| Unknown_InstrumentstIre_Product | 7 | 123 | 0% | 97.4% |
| Unknown Instruments Product | 4 | 23 | 0.8% | 80.5% |
| Simplex P-Japanese Twin Pack | 1 | 1 | 10.6% | 71.5% |
| Stryker | 1 | 5 | 1.3% | 46.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Medtronic Spine | 572 | 11.8% |
| Medtronic Sofamor Danek USA | 491 | 10.1% |
| Medtronic Sofamor Danek | 388 | 8% |
| Depuy Spine | 232 | 4.8% |
| Medos International S Rl Ch | 197 | 4.1% |
| Depuy Synthes Spine | 187 | 3.9% |
| Synthes Selzach | 99 | 2% |
| Stryker Instruments-Kalamazoo | 9 | 0.2% |
| Synthes | 4 | 0.1% |
| Wrights Lane Synthes USA Products | 4 | 0.1% |
| Depuy Cmw - 9610921 | 2 | 0% |
| Stryker Instruments | 2 | 0% |
| Arthrocare | 1 | 0% |
| Carefusion 303 | 1 | 0% |
| Stryker Orthopaedics Limerick | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Leak/splashthe device leaked | 604 | 12.5% |
| Migration or expulsion of device | 547 | 11.3% |
| Improper chemical reaction | 398 | 8.2% |
| Coagulation in device or device ingredient | 354 | 7.3% |
| Fluid/blood leak | 305 | 6.3% |
| Inflation problem | 279 | 5.8% |
| Breakthe device broke | 244 | 5% |
| Material integrity problema problem with the device material | 220 | 4.5% |
| Failure to eject | 207 | 4.3% |
| Chemical problem | 195 | 4% |
| Compatibility problem | 143 | 3% |
| Migrationthe device moved from where it was placed | 106 | 2.2% |
| Insufficient device problem information | 97 | 2% |
| Device operates differently than expectedthe device behaved unexpectedly | 93 | 1.9% |
| Activation, positioning or separation problem | 57 | 1.2% |
| Product quality problem | 57 | 1.2% |
| Device remains implanted | 48 | 1% |
| Fracturea broken bone | 40 | 0.8% |
| Device-device incompatibility | 28 | 0.6% |
| Packaging problem | 28 | 0.6% |
Questions about cement, bone, vertebroplasty reports
What is product code NDN?
FDA's classification code for "Cement, bone, vertebroplasty", class 2, reviewed by the orthopedic panel. Every device report carries the product code of the device involved.
How many reports carry this code?
4,843 reports through August 2026, 615 of them in the latest 12 months.
Which brands appear most often?
Kyphx Hv-R Bone Cement (913), Vertecem V+ Cement Kit (693), KYPHON HV-R Bone Cement (314), Confidence Kit No Needles (175) and Confidence Spinal Cmt Sys 11c (170). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.